English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52869034    線上人數 :  764
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu ta"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 26-75 / 92 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國家衛生研究院 2016-06-07 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors Hsieh, HP;Coumar, MS;Hsu, TA;Wu, SY;Chao, YS
國家衛生研究院 2016-02-09 Pyrazole compounds and thiazole compounds as protein kinases inhibitors Jiaang, WT;Hsu, TA;Lin, WH;Chao, YS
國家衛生研究院 2015-08-20 Fused bicyclic pyrimidine compounds as Aurora kinase inhibitors Coumar, MS;Chao, YS;Hsu, TA;Wu, SY;Hsieh, HP
國家衛生研究院 2015-08 Optimization of quinazoline-based kinase inhibitors: Identification of a dual FLT3/AURKA kinase inhibitor for the treatment of acute myeloid leukemia Hsieh, HP;Hsu, YC;Ke, YY;Shiao, HY;Chang, CW;Lin, WH;Hsu, TA;Yeh, TK;Chen, CT
國家衛生研究院 2015-08 Optimization of furanopyrimidine-based kinase inhibitors: Identification of a BTK kinase inhibitor for the treatment of B cell lymphoma Wang, WC;Hsu, YC;Shiao, HY;Hung, HC;Kuo, CC;Lee, JC;Hsu, TA;Hsieh, HP
國家衛生研究院 2015-08 Discovery of 2,4-diaminopyrimidines bearing a unique pharmacophore as anaplastic lymphoma kinase inhibitors Shiao, HY;Wang, WC;Hsu, YC;Ke, YY;Hsu, TA;Hsieh, HP
國家衛生研究院 2015-07-31 作為極光激酶抑制劑的稠合雙環嘧啶化合物 Hsieh, HP;Coumar, MS;Wu, SY;Hsu, TA;Chao, YS
國家衛生研究院 2015-07-22 作为酪胺酸激酶抑制剂的稠合双环及多环嘧啶化合物 Hsieh, HP;Coumar, MS;Hsu, TA;Lin, WH;Chen, YR;Chao, YS
國立交通大學 2014-12-08T15:06:23Z ON SOME OPTIMAL SELECTION PROCEDURES FOR WEIBULL POPULATIONS HSU, TA
國立交通大學 2014-12-08T15:06:15Z SOME OPTIMAL SUBSET-SELECTION PROCEDURES WITH APPLICATIONS HSU, TA
國家衛生研究院 2014-11 Discovery of multiple kinases inhibitors, DBPR114, as the novel anti-cancer agent Hsieh, HP;Kuo, CC;Chiu, JJ;Hsu, TA;Yeh, TK;Chen, CT
國家衛生研究院 2014-10-29 作為極光激酶抑制劑的稠合雙環嘧啶化合物 Hsieh, HP;Coumar, MS;Hsu, TA;Wu, SY;Chao, YS
國家衛生研究院 2014-10-21 化合物於製造治療病毒感染的藥物之用途 Hsieh, HP;Hsu, TA;Yeh, JY;Horng, JT;Shih, SR;Chang, SY;Chao, YS
國家衛生研究院 2014-10 Novel irreversible EGFR tyrosine kinase inhibitor, DBPR112, as a therapeutic candidate for lung adenocarcinoma Shiao, HY;Hsu, TA;Lin, WH;Yang, TT;Hsieh, HF;Chen, CT;Yeh, TK;Hsieh, HP
國家衛生研究院 2014-04-29 Quinoline compounds and their use for treating viral infection Hsieh, HP;Hsu, TA;Yeh, JY;Chao, YS
國家衛生研究院 2014-04-21 作為蛋白質激酶抑制劑之吡唑化合物及噻唑化合物、其醫藥組成物及用途 Jiaang, WT;Hsu, TA;Lin, WH;Chao, YS
國家衛生研究院 2014-03-20 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors Hsieh, HP;Coumar, MS;Hsu, TA;Wu, SY;Chao, YS
國家衛生研究院 2013-10-01 喹啉化合物及包含其之治療病毒感染之醫藥組成物 Hsieh, HP;Hsu, TA;Yeh, JY;Chao, YS
國家衛生研究院 2013-08-13 Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors Hsieh, HP;Coumar, SM;Hsu, TA;Lin, WH;Chen, YR;Chao, YS
國家衛生研究院 2013-06 Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities Lin, CH;Chang, TC;Das, A;Fang, MY;Hung, HC;Hsu, KC;Yang, JM;Von Itzstein, M;Mong, KKT;Hsu, TA;Lin, CC
國家衛生研究院 2013-02-11 作為酪胺酸激酶抑制劑之稠合雙環及多環嘧啶化合物 Hsieh, HP;Coumar, MS;Chao, YS;Hsu, TA;Lin, WH;Chen, YR
國家衛生研究院 2013-02 Resistance studies of a di-thiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems Lin, HM;Wang, JC;Hu, HS;Wu, PS;Wang, WH;Wu, SY;Yang, CC;Yeh, TK;Hsu, TA;Jiaang, WT;Chao, YS;Chern, JH;Yueh, A
國家衛生研究院 2012-05-11 作為極光激酶抑制劑之稠合雙環嘧啶化合物 Hsieh, HP;Coumar, MS;Hsu, TA;Wu, SY;Chao, YS
國家衛生研究院 2012-04-11 咪唑啉酮及咪唑啉硫酮衍生物 Chern, JH;Hsu, TA;Kang, IJ;Wang, LW;Lee, CC;Lee, YC;Wu, YS;Hsu, SJ;Yueh, YA;Chao, YS
國家衛生研究院 2012-03-20 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors Hsieh, HP;Coumar, MS;Hsu, TA;Wu, SY;Chao, YS
國家衛生研究院 2012-03-01 C型肝炎病毒抑制劑 Chern, JH;Hsu, TA;Kang, IJ;Wang, LW;Lee, CC;Lee, YC;Chao, YS
國家衛生研究院 2012-02 Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents Li, WT;Hwang, DR;Song, JS;Chen, CP;Chen, TW;Lin, CH;Chuu, JJ;Lien, TW;Hsu, TA;Huang, CL;Tseng, HY;Lin, CC;Lin, HL;Chang, CM;Chao, YS;Chen, CT
國家衛生研究院 2012-01 Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor Lin, HM;Wang, JC;Hu, HS;Wu, PS;Yang, CC;Wu, CP;Pu, SY;Hsu, TA;Jiaang, WT;Chao, YS;Chern, JH;Yeh, TK;Yueh, A
國家衛生研究院 2011-12 Development of a whole-cell screening system for evaluation of the human CYP1A2-mediated metabolism Chu, CC;Pan, KL;Yao, HT;Hsu, TA
國家衛生研究院 2011-09-23 BPR1K653, a novel Aurora Kinase Inhibitor, exhibits potent anti-proliferative activity in P-gp170 (MDR1)-mediated VX680-resistant cancer cells in vitro and in vivo Hsieh, HP;Cheung, CHA;Lin, WH;Hsu, TA;Coumar, MS;Chao, YS;Chang, JY
國家衛生研究院 2011-08 BPR1K653, a novel aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cells Cheung, CH;Lin, WH;Hsu, TA;Hour, TC;Yeh, TK;Ko, S;Lien, TW;Coumar, MS;Liu, JF;Lai, WY;Shiao, HY;Lee, TR;Hsieh, HP;Chang, JY
國家衛生研究院 2011-07-26 Hepatitis C virus inhibitors Wang, LW;Hsu, TA;Lee, YC;Kang, IJ;Lee, CC;Chao, YS;Chern, JH
國家衛生研究院 2011-07-11 抑制C型肝炎病毒感染之倍半帖內酯類化合物及其醫藥組成物 Hsieh, HP;Hsu, TA;Hwang, DR
國家衛生研究院 2011-06-21 抑制冠狀病毒之醫藥組合物 Hsu, TA;Hsieh, HP;Chao, YS;Chen, CM;Jan, JT;Liu, HW
國家衛生研究院 2011-06-21 抑制冠狀病毒之醫藥組合物 Hsu, TA;Hsieh, HP;Chao, YS;Chen, CM;Jan, JT;Liu, HW
國家衛生研究院 2011-06-21 抑制冠狀病毒之醫藥組合物 Hsu, TA;Hsieh, HP;Chao, YS;Chen, CM;Jan, JT;Liu, HW
國家衛生研究院 2011-05-10 Imidazolidinone and imidazolidinethione derivatives Chern, JH;Hsu, TA;Kang, IJ;Wang, LW;Lee, CC;Lee, YC;Wu, YS;Hsu, SJ;Yueh, YA;Chao, YS
國家衛生研究院 2011-04 Isatin-beta-thiosemicarbazones as potent herpes simplex virus inhibitors Kang, IJ;Wang, LW;Hsu, TA;Yueh, A;Lee, CC;Lee, YC;Lee, CY;Chao, YS;Shih, SR;Chern, JH
國家衛生研究院 2011-03-01 Thiourea derivatives Chern, JH;Hsu, TA;Kang, IJ;Wang, LW;Lee, CC;Lee, YC;Chao, YS
國家衛生研究院 2011-03 SAR studies of quinoline derivatives as novel anti-influenza agents Ko,SK;Yeh, JY;Horng, JT;Hsu, TA;Hsieh HP
國家衛生研究院 2010-12-01 吲哚化合物 Hsieh, HP;Mahindroo, N;Hsu, TA;Huang, CF;Chen, X;Chao, YS
國家衛生研究院 2010-08-21 硫尿化合物及抑制C型肝炎病毒感染之方法 Chern, JH;Hsu, TA;Kang, IJ;Wang, LW;Lee, CC;Lee, YC;Chao, YS
國家衛生研究院 2010-08 Lead optimization of furanopyrimidine Aurora kinase inhibitors: Development of in vivo active agents in tumor xenograft models Hsieh, HP;Chu, CY;Coumar, MS;Lin, WH;Chen, CT;Hsu, TA;Wu, SY;Chao, YS
國家衛生研究院 2009-11-01 Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors Kang, IJ;Wang, LW;Hsu, SJ;Lee, CC;Lee, YC;Wu, YS;Yueh, A;Wang, JC;Hsu, TA;Chao, YS;Chern, JH
國家衛生研究院 2009-08-01 Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors Kang, IJ;Wang, LW;Hsu, SJ;Lee, CC;Lee, YC;Wu, YS;Hsu, TA;Yueh, A;Chao, YS;Chern, JH
國家衛生研究院 2009-06-09 Treatment of coronavirus infection Hsu, TA;Hsieh, HP;Chao, YS;Chen, CM;Jan, JT;Liu, HW
國家衛生研究院 2009-04-01 Design, synthesis, and anti-HCV activity of thiourea compounds Kang, IJ;Wang, LW;Lee, CC;Lee, YC;Chao, YS;Hsu, TA;Chern, JH
國家衛生研究院 2009-03 Discovery and development of novel furano-pyrimidine analogs as Aurora kinase inhibitors Hsieh, HP;Coumar, MS;Lin, CW;Reddy, GR;Tsai, MT;Lin, WH;Hsu, TA;Wu, SY
國家衛生研究院 2008-12-11 吲哚化合物 Hsieh, HP;Mahindroo, N;Hsu, TA;Huang, CF;Chen, X;Chao, YS
國家衛生研究院 2008-11-11 Indole compounds Hsieh, HP;Mahindroo, NH;Hsu, TA;Huang, CF;Chen, X;Chao, YS

顯示項目 26-75 / 92 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目